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SUMMARY 
Medication nonadherence is a significant burden to health care utilization[1], in addition to poor disease 
control. But there is a paucity of structured adherence counselling as a thematic area of care. We have used a 
modified adherence tool for patients living with HIV and AIDs which incorporates social background, treatment 
preparation, adherence habits, disclosure of illness, the use of treatment partners, and assessment of potential 
barriers to adherence. This form was designed only to explore known characteristics that are important for 
adherence, but patients were asked to make judgement on their own level of adherence. 
Of the one hundred and eighty one eighty six (47.5%) were males while 95(52.5%) were females. The mean 
age was 50.83years (SD 12.54). Majority of the patients were married (81.8%) and had at least primary 
education. Most of the patients whom we interviewed were hypertensives (65%). One hundred and twelve 
(61.88%) were taking medications during a daily routine, such as eating. Most of the patients, 116(64.10%) 
had some knowledge about their illness and the medications they were taking by names. Majority of patients 
(72.4%) had disclosed their illness to their spouses. Many patients selfreport that their adherence is good. 
[Afr J Health Sci. 2013; 25:128135] 
Introduction 
Adherence to medications used for treatment of chronic 
illnesses such as hypertension and diabetes mellitus 
has generally be regarded as poor[24], even though 
these diseases account for great burden of morbidity 
and mortality worldwide, and particularly in sub
Saharan Africa[5]. This is despite the fact that 
medications for treatment of hypertension and diabetes 
are cheaper due to availability of generic products. 
Adherence factors are generally patient/caregiver or 
health provider related. Patient related factors are very 
important and are the most effective in overcoming 
barriers to adherence. They are also the most 
significant modifiable factors [6, 7]. Medication non
adherence is a significant burden to health care 
utilization[1] in addition to poor disease control. 
Although health awareness is a prominent feature of 
patient’s participation in management of chronic 
diseases in most clinics now, there is a paucity of 
structured adherence counselling as a thematic area of 
care. This is a key feature in the care of patients living 
with HIV and AIDS where a near perfect adherence to 
antiretroviral therapy is critical for viral suppression. 
This model of care provides an opportunity to first 
explore factors that may enhance or hinder adherence 
in our hypertension/diabetic clinic and then incorporate 
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this as part of the comprehensive care for hypertension 
and diabetes. These factors include gender, age, 
marital status, educational status, treatment preparation, 
level of awareness of illness, and patients’ perception 
of sources of barriers to medication adherence. We 
assessed these factors in our hypertensive and diabetic 
patients in order to determine medication adherence 
among them later. 
 
Methods 
As part of the scaleup of HIV and AIDS care in 
Nigeria, a comprehensive approach to patient 
management was institutionalized. There was 
development of manpower in the areas of clinical care, 
counselling, prevention of mother to child, laboratory 
services, community care, and adherence counselling.  
Because of the biology and interaction of the virus with 
the antiretrovirals, a rigorous adherence counselling 
was deemed critical for the overall success of the 
programme. The aim was to achieve ≥95% adherence 
to the medications [8]. A tool was developed for 
patients’ assessment at every clinic visit. This is called 
Medication Assessment and Work Plan.  It incorporates 
social background, treatment preparation, adherence 
habits, disclosure of illness, the use of treatment 
partners, and assessment of potential barriers to 
adherence. Two adherence counsellors for patients 
living with HIV and AIDS were trained for the purpose 
of administering a modified form of this tool for the 
hypertension/diabetes clinic. The questionnaire was 
translated into patient’s language where necessary. 
This form was designed only to explore known 
characteristics that are important for adherence, but 
patients were asked to make judgement on their own 
level of adherence. Knowledge of patient characteristics 
and adherence habits will be important in instituting a 
workplan tailored for the hypertension and diabetes 
clinic. The questionnaire was divided into three parts: 
patients’ demographic and clinical characteristics, 
measures to improve adherence, and patients’ own 
opinion about their adherence. An approximate 
calculated adherence was made based on days of 
missed doses in the previous one month as follow: 58 
days or can’t remember = poor, 14 days = good, none 
= excellent. The questionnaire was pretested. 
Two hundred patients were randomly selected in our 
hypertension clinic and interviewed using the 
questionnaire. No formal adherence education or any 




A total of one hundred and eighty one (90.5%) 
questionnaires had complete data and these were 
analysed (Table 1). Eighty six (47.5%) were males 
while 95(52.5%) were females. The mean age was 
50.83years (SD 12.54). Majority of the patients were 
married (81.8%). Thirty four (18.8%) were illiterate or 
had no formal education while 41 (22.7), thirty seven 
(20.4%) and 38(21.0%) had primary, secondary and 
tertiary (but not university) education respectively. Thirty 
one (17.1%) had university education. Most of the 
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Table1. Patients’ demographics 
       Number   (%)  Mean (SD) 
Gender 
  Male        86 (47.5) 
  Female                       95 (52.5)  
Age          50.83(12.54) 
  Male        51.73(12.28) 
  Female        50.35(12.82) 
Marital status 
  Single     13 (7.2) 
  Married     148 (81.8) 
  Widows/widowers    20 (11.0)   
Highest level of education 
  None/illiterate    34 (18.8) 
  Primary     41 (22.7) 
  Secondary    37 (20.4) 
  Tertiary but not University  38 (21.0) 
       
  University    31 (17.1) 
Diagnosis 
  Hypertension    119 (65.7) 
  Diabetes    21 (11.6) 
  Hypertension and Diabetes     41 (22.7) 
       
On selfhelp measures and other means of enhancing 
adherence, one hundred and twelve (61.88%) were 
taking medications during a daily routine, such as 
eating (Table 2). Seventeen had (9.40%) had treatment 
partner, only three (1.66%) used electronic devices 
such as alarms to enhance adherence. Forty eight 
(26.52%) did not use any specific means to enhance 
adherence to medication.   
Table 2.  Measures to improve adherence 
Treatment Preparation                Number (%)   
Treatment partner               17 (9.40) 
Alarm/text messages               3 (1.66) 
Taking medications during daily routine    112 (61.88) 
Educational module      1 (0.55) 
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Awareness of illness and medication 
  Personal knowledge of illness and medication 
    Yes    116 (64.10) 
    No    65 (35.90) 
  Who is aware of illness? 
    Nobody             3 (1.70) 
    Spouse    131 (72.4) 
    Children            32 (17.6) 
    Siblings    9 (5.0) 
    Parents    4 (2.21) 
Perceived sources of barriers to adherence 
      Patient/caregiver related 
  Knowledge of disease    40 (22.1) 
  Cost of drugs     35 (19.3) 
  None      106 (58.6) 
     Health facility/Health team related 
  Trust and confidence   32 (17.7) 
  Poor communication   17 (9.4) 
  Waiting time    68 (37.6) 
  None     64 (35.4) 
 
Most of the patients, 116(64.10%) had some 
knowledge about their illness and the medications they 
were taking by names. One hundred and thirty one 
(72.4%) said their spouses were aware of their illness, 
while in thirty two (17.6%), the children were aware.  
Regarding perceived sources of barriers to adherence 
related to the patients themselves or their relatives, 
forty (22.1%) and thirty five (19.3%) said that 
knowledge of the disease and cost of drugs respectively 
could be factors affecting adherence. One hundred and 
six (58.6%) said that they did not perceive anything in 
themselves that could potentially affect adherence. For 
32 (17.7%) patients, trust and confidence in the health 
team/facility, communication in 17 (9.4%) and waiting 
time in 68 (37.6%) and could be factors affecting 
adherence. Sixty four (35.4%) did not perceive 
anything in the health team/facility that could be a 
factor affecting adherence. One hundred and eight 
(59.67%) judged their own adherence to be good 
based on their own assessment, while 60 (33.1%) said 
it was excellent. When we then asked them to recall 
how many days in the past one month they had missed 
their doses, thirty eight (20.99%)  had missed in 14 
days, 12 (6.63%)  in 58 days and one hundred and 
nineteen (65.75%) said they had not missed any 
doses. Based on the number of days doses of drugs 
were missed, we made an approximate calculation of 
levels of adherence. Twenty four patients (13.26%), 38 
(20.99%) and 113 (65.75%) had poor, good and 
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Table 3. Levels of adherence 
     Number (%) 
Selfassessment of adherence  
 Poor     13 (7.2) 
 Good    108 (59.67) 
 Excellent   60 (33.1) 
Days of missed doses in the past one month 
 14 days   38 (20.99) 
58 days   12 (6.63) 
 Can’t remember  12 (6.63) 
 None    119 (65.75) 
Approximate calculated adherence based on days of missed doses in the past month 
 Poor    24 (13.26) 
 Good    38 (20.99) 
   Excellent   119 (65.75)  
Discussion 
This study has investigated the common known risk 
factors for poor adherence to medication in our adult 
hypertensive and diabetic patients who attend our clinic. 
As previously documented, medication adherence is not 
generally optimal, and many factors are responsible for 
this, especially in developing countries where non
adherence may be as low as 63.4%[9]. Even in 
developed world, adherence to antihypertensive 
medications is relatively poor, particularly among the 
minorities[10]. The mean age of our study population is 
about 51 years. Challenges of adherence are not 
similar for both adolescent and adult population. For 
example in adolescents, stage of maturity and certain 
emotional problems are very relevant[11]. Younger age 
is a factor of  poor adherence [12]. Majority of patients 
(81.8%) interviewed in this study were married. A 
spouse would be an ideal treatment partner in a chronic 
disease such as hypertension or diabetes, especially 
when disclosure of illness would not be a challenge in a 
marriage relationship. Even in adolescents or unmarried 
people, disclosure enhances adherence to therapy[13].     
 Most of the patients had some level of education (only 
34% having no form of education or completely 
illiterate), and this is a key factor in improving 
adherence, as demonstrated by Burge, SK et al in their 
study which demonstrated that higher education, among 
other things, were associated with medication 
knowledge and adherence[14]. Higher level of 
education would facilitate communication and 
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Treatment preparation involves education of patient on 
the nature of their illness, focused group discussion on 
how to enhance adherence, psychological assessment 
on readiness, possible side effects of drugs, addressing 
patients’ fears and apprehension about medications, 
awareness on the need to take medications and self
help measures to enhance adherence[15]. Majority of 
the patients interviewed (61.88%) take medications 
during a daily routine such as eating. Most people 
would intuitively take their medication at the most 
convenient time which is during or after a meal, usually 
the breakfast and or dinner when they are at home. 
Fortunately most antihypertensive and antidiabetic 
drugs are taken once or twice a day. Only a minority of 
patients use self help measures such as treatment 
partner (someone who, among other things, reminds 
and encourages patient to take medications) and 
electronic devices or alarms, possibly because they are 
more complex even though this have been 
demonstrated to improve adherence in a study of 
elderly patients[16]. It seems, then, that one of the best 
ways to enhance medication adherence is reinforcing 
the practice of taking medications during a daily routine 
such as meals. 
Almost two thirds of the patients interviewed had some 
knowledge about their medications and illness. This 
would normally arise from adequate information and 
interaction by all staff of the clinic with patients. Health 
talk is a part and parcel of our clinic activities. During 
this period, patients ask questions about their illness 
and medications. When patients are pleased with their 
clinic consultation they are more likely to adhere to 
therapy[17]. Conversely, when patients are not 
motivated, have not received adequate health 
education, and are not fully aware of the nature of their 
illness, their adherence to medications would be 
poor[3].  
 Family and social support, and hence disclosure of 
illness which is easier in nonstigmatizing illnesses like 
hypertension and diabetes, are known to enhance 
adherence[18, 19]. Majority of those interviewed said 
their spouses were aware of their illness. Though this in 
itself is not a guarantee of support, but in a relatively 
stable family setup, this can be a focus of intervention 
for improving adherence. A spouse may lend support 
by reminding the other about taking medication, or a 
husband providing financial support to attend clinic and 
purchase medication. A woman in purdah or in a 
culture where she cannot go out without permission or 
a company would get a better support if her husband is 
aware of her illness. Only a minority of patients believe 
that knowledge of disease and cost of drugs could not 
be factors affecting adherence, nor do they also believe 
that factors relating to the health facilities could be 
factors affecting adherence. This agrees with an earlier 
report demonstrating that interviews have lower 
concordance compared with questionnaires or 
diaries[20]. Therefore, without an intervention such as 
peer education, focused group discussion, provision and 
availability of educational materials this may not be 
appreciated.  Furthermore, patients are more likely to 
exaggerate their adherence or have the sense that they 
are doing all that needs to be done. It is not surprising 
that 59.67% and 33.10% judged their adherence to be 
good and excellent respectively. Sixty five percent said 
they had not missed any dose of their medications in 
the previous one month. An estimate of adherence 
based on selfreport showed an excellent adherence in 
over 65% of the interviewees.  
Conclusions 
Our study has identified certain factors of adherence to 
antihypertensive and antidiabetic medications. This 
study has only explored factors that may affect 
adherence which may be areas of attention and 
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intervention in our hypertensive and diabetic patients; 
we have not objectively assessed adherence in them. 
We hope to introduce this tool for intervention in order 
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